A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes
PHASE3
This trial is conducted in Asia. The aim of the trial is to investigate saf...
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
PHASE3
The purpose of this trial is to examine the efficacy and safety of once-wee...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.